Growth Factor Alternative Peptide

For the increased efficiencies and cost reduction in R&D and manufacturing of cell products.

PeptiGrowth is utilizing the proprietary technology of its shareholder PeptiDream to develop “Growth Factor Alternative Peptide” that performs equivalent functions to conventional growth factors. “Growth Factor Alternative Peptide” are manufactured solely through the use of chemical synthesis to solve many challenges of conventional growth factors.
By delivering products with consistent quality across manufacturing lots, experimental data repeatability is high and with better handling characteristics and easier contaminant management at a fair price, significant efficiency improvement and cost reduction in R&D and manufacturing activities for regenerative medicine and cell therapy can be achieved.

Comparison to conventional growth factors

	Fetal bovine serum growth factor	Recombinant Growth Factor	Growth Factor Alternative Peptide
Variation in quality among manufacturing lots	Inconsistent	Consistent	Consistent Improved data reproducibility
Non-biological Origin	Biological Origin	Non-biological Origin	Non-biological Origin Easy impurity management
Stability	Low	Low	High Easy product handling
Price	High Price	Very High Price	Reasonable Price Cost reductions

Growth Factor Alternative Peptide
Now available

• PG-001HGF Alternative Peptide (c-Met Agonist)
• PG-002TGFβ1 Inhibitor (TGFβ1 Binding Peptide)
• PG-003BDNF Alternative Peptide (TrkB Agonist)
• PG-004Noggin-like peptide (BMP4,7 Inhibitor)
• PG-005BMP7 Selective Inhibitor
• PG-006BMP4 Selective Inhibitor
• PG-007VEGF Alternative Peptide (VEGFR2 agonist)
• PG-008Wnt3a Alternative Peptide (β-catenin pathway agonist)
• PG-009Synthetic EGF
• PG-010TPO Alternative Peptide (TPOR agonist)
• PG-011FGF2 Alternative Peptide (FGFR1c agonist)